1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Cutaneous T-cell Lymphoma Stage I: new trials by email Literature Review of Cutaneous T-cell Lymphoma Stage I trials Research Report on Cutaneous T-cell Lymphoma Stage I
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechlorethamine Induced Contact Dermatitis Avoidance Study Triamcinolone, Valchlor 0.016 % Topical Gel - Cutaneous T-cell Lymphoma, Cutaneous T-cell Lymphoma Stage I | Phase 2 | Completed | Rochester Skin Lymphoma Medical Group, PLLC | 28 | 2017-12-13 | 2026-09-04 |
| Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma vorinostat, flow cytometry, laboratory biomarker analysis - Cutaneous T-cell Lymphoma Stage I, Cutaneous T-cell Lymphoma Stage II | Phase 2 | Terminated | University of Washington | 11 | 2009-07-01 | 2018-10-18 |
Lymphoma, T-Cell, Cutaneous (2) · Dermatitis, Contact (1) · Mycosis Fungoides (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma, T-Cell (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Dermatitis (1) · Skin Diseases (1) · Skin Diseases, Eczematous (1) · Skin and Connective Tissue Diseases (1)
Amines (1) · Flow Cytometry (1) · Gels (1) · Mechlorethamine (1) · Ointments (1) · Triamcinolone (1) · Triamcinolone Acetonide (1) · Vorinostat (1)
Rochester Skin Lymphoma Medical Group, PLLC (1) · University of Washington (1)
United States (2)
Andrei Shustov (1) · Brian Poligone, MD, PhD (1)